A new ArmeoPower exoskeleton device has been launched for integrated arm and hand rehabilitation for patients that have had a stroke.
Hocoma, a global leader in robotic and sensor-based devices for functional movement therapy, have designed the device with an integrated robotic hand module called ‘ManovoPower’, to offer simultaneous therapy from an individual’s shoulder to their fingers, providing a complete movement chain.
Dr Vaclav Potesil, Armeo product manager at Hocoma, said: “The device provides hospitals with an enriched environment to train and assess even severely impaired patients with much higher intensity, accuracy and reproducibility than what is possible in today’s clinical setting. The new therapy planning and reporting enables clinicians to tailor the therapy to each patient, thereby keeping them challenged and motivated.”
